Rankings
▼
Calendar
DXCM Q4 2025 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena
DXCM
DexCom, Inc.
$27B
Q4 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$1.3B
+13.1% YoY
Gross Profit
$793M
62.9% margin
Operating Income
$323M
25.6% margin
Net Income
$267M
21.2% margin
EPS (Diluted)
$0.67
QoQ Revenue Growth
+4.2%
Cash Flow
Operating Cash Flow
$294M
Free Cash Flow
$192M
Stock-Based Comp.
$35M
Balance Sheet
Total Assets
$6.3B
Total Liabilities
$3.6B
Stockholders' Equity
$2.7B
Cash & Equivalents
$918M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.1B
+13.1%
Gross Profit
$793M
$656M
+20.9%
Operating Income
$323M
$189M
+71.0%
Net Income
$267M
$152M
+76.2%
Geographic Segments
Non-US
$368M
100%
← FY 2025
All Quarters